LLY and BIIB Related Headlines
Go Back- Barclays launches U.S. biopharma coverage with four preferred picks
- RBC: 'We have just confirmed that a recent clinicaltrials.gov listing for a new drug called BIIB145'
- Bernstein on Novo's Alzheimer's miss: 'Don't expect Lilly to stay quiet'
- Trump: tariffs will get countries to agree to drug pricing plan
- RBC says Lilly could blaze trail and Biogen could pull ahead in Alzheimer’s market
- Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'
